P10827 | SWISS-MODEL Repository

P10827 (THA_HUMAN) Homo sapiens (Human)

Thyroid hormone receptor alpha UniProtKB InterPro STRING Interactive Modelling

490 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4); 2 identical sequences: Pan troglodytes: K7AAN9, A0A803KIN3

It is possible new templates exist for this target since these models were created.

Available Structures

9 Experimental Structures

Description	PDB ID	Oligo-state	Range	Ligands
Structure of TR-alfa bound to selective thyromimetic GC-1 in P212121 space group	3ilz SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	148-370	1×B72;
Assess
Crystal Structure of human TR alpha bound T3 in orthorhombic space group	2h79 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	148-370	1×T3;
Assess
Crystal structure of TR-alpha bound to T3 in a second site	4lnw SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	148-370	2×T3;
Assess
Crystal Structure of TR-alfa bound to the selective thyromimetic TRIAC	3jzb SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	148-370	1×4HY;
Assess
Crystal structure of TR-alpha bound to T4 in a second site	4lnx SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	148-370	1×T44; 1×T3;
Assess
Structure of TR-alfa bound to selective thyromimetic GC-1 in C2 space group	3hzf SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	148-370	1×B72;
Assess
Thyroid Receptor Alpha in complex with an agonist selective for Thyroid Receptor Beta1	1nav SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	148-370	1×SO4; 1×IH5;
Assess
Crystal structure of human TR alpha bound T3 in monoclinic space group	2h77 SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	152-370	1×T3;
Assess
Crystal structure of a mutant (P393GX) Thyroid Receptor Alpha ligand binding domain designed to mod…	7qdt SMTL PDBe PDBe-KB PDBj PDBsum RCSB	monomer	156-370	1×T3;
Assess

14 SWISS-MODEL models

Template	Oligo-state	QMEANDisCo	Range	Ligands	Trg-Tpl Seq id (%)
5uan.1.B	monomer	0.64	52-383	1×ZN;	40.65
Assess
7wnh.3.A	monomer	0.59	52-383	1×ZN;	31.83
Assess
7wnh.2.A	monomer	0.59	52-383	2×ZN;	31.83
Assess
4nqa.2.B	monomer	0.58	49-383	2×ZN;	29.94
Assess
3dzy.1.B	monomer	0.58	50-383	1×ZN;	30.96
Assess
4nqa.1.B	monomer	0.57	49-383	1×ZN;	29.94
Assess
4iqr.2.A	monomer	0.56	51-376	2×ZN;	30.58
Assess
7prw.1.A	monomer	0.56	47-376	2×ZN;	18.57
Assess
4iqr.2.B	monomer	0.55	51-376	2×ZN;	30.58
Assess
7kw7.1.F	monomer	0.54	166-376		19.02
Assess
7prw.1.B	monomer	0.54	50-376	2×ZN;	18.57
Assess
3dzy.1.A	monomer	0.53	50-376	2×ZN;	32.80
Assess
4nqa.1.A	monomer	0.53	44-370	2×ZN;	33.11
Assess
5uan.1.A	monomer	0.50	51-370	2×ZN;	33.11
Assess

Model ID	Oligo-state	Avg pLDDT	Range	Trg-Mdl Seq Id (%)

Model ID	Oligo-state	Avg Confidence	Range	Trg-Mdl Seq id (%)

40 SWISS-MODEL models built on isoform sequence

Template	Isoform	Oligo-state	QMEANDisCo	Range	Ligands	Trg-Tpl Seq id (%)
Isoform 2	5uan.1.B	monomer	0.64	52-406	1×ZN;	40.77
Assess
Isoform 2	7wnh.2.A	monomer	0.61	52-405	2×ZN;	30.95
Assess
Isoform 2	7wnh.4.A	monomer	0.60	53-408	1×ZN;	30.95
Assess
Isoform 2	4nqa.1.B	monomer	0.59	49-406	1×ZN;	28.77
Assess
Isoform 2	4nqa.2.B	monomer	0.59	49-407	2×ZN;	28.77
Assess
Isoform 2	3dzy.1.B	monomer	0.58	50-407	1×ZN;	31.90
Assess
Isoform 2	4nqa.1.A	monomer	0.58	47-406	2×ZN;	28.57
Assess
Isoform 2	4iqr.1.A	monomer	0.58	51-407	2×ZN;	28.97
Assess
Isoform 2	4iqr.1.B	monomer	0.56	51-407	2×ZN;	28.97
Assess
Isoform 2	7prw.1.A	monomer	0.56	47-408	2×ZN;	17.99
Assess
Isoform 2	5uan.1.A	monomer	0.56	51-407	2×ZN;	28.57
Assess
Isoform 2	7prv.1.B	monomer	0.55	50-408	2×ZN;	17.99
Assess
Isoform 2	3dzy.1.A	monomer	0.55	50-405	2×ZN;	28.13
Assess
Isoform 2	4nqa.2.A	monomer	0.54	43-378	1×ZN;	34.29
Assess
Isoform 3	5uan.1.B	monomer	0.63	52-409	1×ZN;	37.72
Assess
Isoform 3	7wnh.2.A	monomer	0.59	52-408	2×ZN;	30.84
Assess
Isoform 3	7wnh.4.A	monomer	0.59	53-409	1×ZN;	30.84
Assess
Isoform 3	3dzy.1.B	monomer	0.58	50-409	1×ZN;	30.64
Assess
Isoform 3	4nqa.1.A	monomer	0.57	47-409	2×ZN;	28.40
Assess
Isoform 3	4nqa.1.B	monomer	0.57	49-409	1×ZN;	28.93
Assess
Isoform 3	4iqr.2.A	monomer	0.57	51-410	2×ZN;	29.28
Assess
Isoform 3	4nqa.2.B	monomer	0.57	49-410		28.93
Assess
Isoform 3	4iqr.2.B	monomer	0.55	51-410	2×ZN;	29.28
Assess
Isoform 3	3e00.1.A	monomer	0.55	50-408	2×ZN;	28.35
Assess
Isoform 3	5uan.1.A	monomer	0.55	51-410	2×ZN;	28.40
Assess
Isoform 3	7prw.1.A	monomer	0.54	47-410	2×ZN;	17.99
Assess
Isoform 3	7prw.1.B	monomer	0.53	50-410	2×ZN;	17.99
Assess
Isoform 4	5uan.1.B	monomer	0.63	52-406	1×ZN;	37.98
Assess
Isoform 4	7wnh.2.A	monomer	0.59	52-405	2×ZN;	30.15
Assess
Isoform 4	7wnh.4.A	monomer	0.59	53-407	1×ZN;	30.15
Assess
Isoform 4	4nqa.1.B	monomer	0.58	49-406	1×ZN;	28.45
Assess
Isoform 4	3dzy.1.B	monomer	0.57	50-407	1×ZN;	30.55
Assess
Isoform 4	4nqa.1.A	monomer	0.57	47-406	2×ZN;	27.96
Assess
Isoform 4	4iqr.2.A	monomer	0.57	51-406	2×ZN;	29.06
Assess
Isoform 4	4nqa.2.B	monomer	0.57	49-406		28.45
Assess
Isoform 4	3dzu.1.A	monomer	0.56	50-405	2×ZN;	27.52
Assess
Isoform 4	4iqr.2.B	monomer	0.55	51-406	2×ZN;	29.06
Assess
Isoform 4	5uan.1.A	monomer	0.55	51-407	2×ZN;	27.96
Assess
Isoform 4	7prw.1.A	monomer	0.55	47-407	2×ZN;	17.80
Assess
Isoform 4	7prv.1.B	monomer	0.53	50-407	2×ZN;	17.80
Assess

P10827 (THA_HUMAN) Homo sapiens (Human)

Thyroid hormone receptor alpha UniProtKBInterProSTRINGInteractive Modelling

Available Structures

9 Experimental Structures

14 SWISS-MODEL models

40 SWISS-MODEL models built on isoform sequence

Alignments

Background

Resolution

Thyroid hormone receptor alpha UniProtKB InterPro STRING Interactive Modelling